Hohimer Wealth Management LLC Takes Position in Danaher Corporation $DHR

Hohimer Wealth Management LLC bought a new position in Danaher Corporation (NYSE:DHR) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,189 shares of the conglomerate’s stock, valued at approximately $2,218,000.

Other large investors have also added to or reduced their stakes in the company. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter valued at $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher in the second quarter worth $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the third quarter valued at $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher during the third quarter valued at $28,000. Finally, Tripletail Wealth Management LLC bought a new position in Danaher in the third quarter valued at about $31,000. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Price Performance

Shares of NYSE:DHR opened at $209.35 on Friday. The company has a market capitalization of $148.04 billion, a P/E ratio of 41.54, a P/E/G ratio of 2.83 and a beta of 0.91. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80. The firm’s 50 day simple moving average is $225.62 and its two-hundred day simple moving average is $216.09. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same period in the prior year, the company posted $2.14 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Research analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a $0.40 dividend. The ex-dividend date is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Morgan Stanley initiated coverage on Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 price target for the company. Guggenheim raised their price objective on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 2nd. Evercore reaffirmed an “outperform” rating and set a $254.00 target price on shares of Danaher in a report on Wednesday, January 28th. Robert W. Baird set a $251.00 price target on shares of Danaher in a research report on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $253.86.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.